Literature DB >> 400820

Stepwise acquisition of multiple drug resistance by beta-hemolytic streptococci and difference in resistance pattern by type.

Y Miyamoto, K Takizawa, A Matsushima, Y Asai, S Nakatsuka.   

Abstract

We collected 1,353 strains of beta-hemolytic streptococci of groups A, B, C, and G (1,176 strains of which were group A) isolated in 26 institutions throughout Japan in 1972-1974. The strains were grouped and T-typed by our specific group-and T-factor sera, and the minimal inhibitory concentrations of 10 antibiotics were assayed by the standard method. Resistant strains from the above collection were classified according to group, T-type, and drug resistance pattern. Our data on T-types for 1964-1971 and on drug resistance for 1966-1971 were used to interpret the detected long-term variations in T-type and drug resistance. The stepwise acquisition of multiple drug resistance, the difference in resistance pattern between predominant T-types, and the rarity of single-macrolide resistance were demonstrated.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 400820      PMCID: PMC352252          DOI: 10.1128/AAC.13.3.399

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  14 in total

1.  IN VITRO SUSCEPTIBILITY OF GROUP A BETA HEMOLYTIC STREPTOCOCCI TO 18 ANTIBIOTICS.

Authors:  T C EICKHOFF; M FINLAND; C WILCOX
Journal:  Am J Med Sci       Date:  1965-03       Impact factor: 2.378

2.  The sensitivity of staphylococci and other wound bacteria to erythromycin, oleandomycin, and spiramycin.

Authors:  E J LOWBURY; L HURST
Journal:  J Clin Pathol       Date:  1959-03       Impact factor: 3.411

3.  An outbreak of pharyngitis due to tetracyclineresistant group A, type 12 streptococci.

Authors:  W J MOGABGAB; W PELON
Journal:  AMA J Dis Child       Date:  1958-12

4.  Tetracycline resistance of group A beta hemolytic streptococci.

Authors:  H A KUHARIC; C E ROBERTS; W M KIR BY
Journal:  JAMA       Date:  1960-12-03       Impact factor: 56.272

5.  Susceptibility of beta-hemolytic streptococci to 65 antibacterial agents.

Authors:  M Finland; C Garner; C Wilcox; L D Sabath
Journal:  Antimicrob Agents Chemother       Date:  1976-01       Impact factor: 5.191

6.  Aureomycin and erythromycin therapy for str. pyogenes in burns.

Authors:  E J LOWBURY; J S CASON
Journal:  Br Med J       Date:  1954-10-16

7.  Chloramphenicol-, dihydrostreptomycin-, and kanamycin-inactivating enzymes from multiple drug-resistant Escherichia coli carrying episome 'R'.

Authors:  S Okamoto; Y Suzuki
Journal:  Nature       Date:  1965-12-25       Impact factor: 49.962

8.  Transduction of drug resistance to tetracycline, chloramphenicol, macrolides, lincomycin and clindamycin with phages induced from Streptococcus pyogenes.

Authors:  K Ubukata; M Konno; R Fujii
Journal:  J Antibiot (Tokyo)       Date:  1975-09       Impact factor: 2.649

9.  [Drug sensitivity of Streptococcus haemolyticus ecently isolated from patients with scarlet fever with special reference to the advent of an erythromycin-resistant strain].

Authors:  K Misuno; A Hirayama; R Yoshida
Journal:  Kansenshogaku Zasshi       Date:  1972-03

10.  Resistance mechanism of chloramphenicol in Streptococcus haemolyticus, Streptococcus pneumoniae and Streptococcus faecalis.

Authors:  S Miyamura; H Ochiai; Y Nitahara; Y Nakagawa; M Terao
Journal:  Microbiol Immunol       Date:  1977       Impact factor: 1.955

View more
  8 in total

1.  Phenotypes and genotypes of erythromycin-resistant Streptococcus pyogenes strains in Italy and heterogeneity of inducibly resistant strains.

Authors:  E Giovanetti; M P Montanari; M Mingoia; P E Varaldo
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

2.  Streptococcal tetracycline resistance mediated at the level of protein synthesis.

Authors:  V Burdett
Journal:  J Bacteriol       Date:  1986-02       Impact factor: 3.490

3.  Susceptibility of group A beta-hemolytic streptococci in the lower St Lawrence region, Quebec.

Authors:  A Desrosiers; P Dolcé; P Jutras; L P Jetté
Journal:  Can J Infect Dis       Date:  1999-07

4.  Identification of tetracycline-resistant R-plasmids in Streptococcus agalactiae (group B).

Authors:  V Burdett
Journal:  Antimicrob Agents Chemother       Date:  1980-11       Impact factor: 5.191

5.  Resistance to macrolides in Streptococcus pyogenes in France in pediatric patients.

Authors:  E Bingen; F Fitoussi; C Doit; R Cohen; A Tanna; R George; C Loukil; N Brahimi; I Le Thomas; D Deforche
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

6.  Decreased activity of erythromycin against Streptococcus pyogenes in Taiwan.

Authors:  P R Hsueh; H M Chen; A H Huang; J J Wu
Journal:  Antimicrob Agents Chemother       Date:  1995-10       Impact factor: 5.191

7.  Increased prevalence of group A streptococcus isolates in streptococcal toxic shock syndrome cases in Japan from 2010 to 2012.

Authors:  T Ikebe; K Tominaga; T Shima; R Okuno; H Kubota; K Ogata; K Chiba; C Katsukawa; H Ohya; Y Tada; N Okabe; H Watanabe; M Ogawa; M Ohnishi
Journal:  Epidemiol Infect       Date:  2015-03       Impact factor: 4.434

8.  Bacteriological and clinical efficacy of various antibiotics used in the treatment of streptococcal pharyngitis in Italy. An epidemiological study.

Authors:  G Rondini; C E Cocuzza; M Cianflone; A Lanzafame; L Santini; R Mattina
Journal:  Int J Antimicrob Agents       Date:  2001-07       Impact factor: 5.283

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.